so you don't think the company is worth 17 million now. Vical has ebola, cmv in phase 3 & 2 trials, did not give up on herpes yet, manufacturing facility, zero debt, and hopefully a replacement for our current CEO.
and A few more positives I did not mention. How about the partnership with Astellas Pharm?
Why doesn't some pharm buyout Vical. ? Surely it is worth considerably more. Astellas pharma located in Illinois has sales of 2.9 billion. Vical Looks like the most undervalued stock out there in the market despite the major failures of recent trials. Looks like a perfect fit for Astellas pharm